FactorPad
Build a Better Process

Stock Risk Measures for Regeneron Pharmaceuticals

A quantitative factor review as of September 30, 2021.
  1. Company Info - Description, identity and sector data.
  2. Share Data - Stock earnings and key dates.
  3. Market Risk - Beta, size, liquidity and momentum measures.
  4. Financial Risk - Earnings and dividends.
face pic by Paul Alan Davis, CFA
Updated: October 05, 2021
See how we arrive at an overall risk score of 33 for REGN below.

/ factorpad.com / stocks / f53zmj.html


An ad-free and cookie-free website.


REGN Risk Report

Overview

Our quantitative data points are meant to provide a high-level understanding of factors in equity risk models for Regeneron Pharmaceuticals. Portfolio managers use these models to forecast risk, optimize portfolios and review performance.

We show how REGN stock compares to 2,000+ US-based stocks, and to peers in the Manufacturing sector and Pharmaceutical Preparation Manufacturing industry.

Please do not consider this data as investment advice. Data is downloaded from sources we deem reliable, but errors may occur.

Company Info

Business Description

Company logo Regeneron is a leading biotechnology company that invents life-transforming medicines for people with serious diseases. Founded and led for over 30 years by physician-scientists, its unique ability to repeatedly and consistently translate science into medicine has led to nine FDA-approved treatments and numerous product candidates in development, almost all of which were homegrown in its laboratories. Its medicines and pipeline are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, pain, infectious diseases and rare diseases.

Identity

Sector and Industry

Share Data

Shares

Earnings and Dividends

Market Risk Measures

Many of the following risk metrics are standardized and transformed into quantitative factors in institutional-level risk models.

Rankings below represent percentiles from 1 to 100, with 1 being the lowest rating of risk.

Systematic Risk

Stocks with higher beta exhibit higher sensitivity to the ups and downs in the market. (↑↑)

Company Size

Stocks with higher market capitalization often have lower risk. (↑↓)

Trading Liquidity

Higher average daily dollar volume over the past 30 days implies lower liquidity risk. (↑↓)

Price Momentum

Higher price momentum stocks, aka recent winners, equate to lower risk for many investors. (↑↓)

Financial Risk Measures

Style risk factors often include measures of profitability and payout levels.

Earnings Yield

Companies with higher earnings generally provide lower risk. (↑↓)

Dividend Yield

Companies with higher dividend yields, if sustaintable, are perceived to have lower risk. (↑↓)

/ factorpad.com / stocks / f53zmj.html


REGN stock risk
REGENERON PHARMACEUTICALS stock beta
REGN risk report
REGN f53zmj
REGN risk analysis
REGN volatility
REGENERON PHARMACEUTICALS credit risk
REGN liquidity risk
REGN leverage
REGN valuation
REGN systematic risk
REGN specific risk
REGENERON PHARMACEUTICALS volatility
REGN analysis
REGN financial ratio

A newly-updated free resource. Connect and refer a friend today.